Name Development Level Target Family
Tumor necrosis factor Tclin Non-IDG
T-lymphocyte activation antigen CD86 Tclin Non-IDG
T-lymphocyte activation antigen CD80 Tclin Non-IDG
Name Description
etanercept A recombinant version of soluble human TNF receptor that binds specifically to TUMOR NECROSIS FACTOR and inhibits its binding with endogenous TNF receptors. It prevents the inflammatory effect of TNF and is used to treat RHEUMATOID ARTHRITIS; PSORIATIC ARTHRITIS and ANKYLOSING SPONDYLITIS.
TCRDv4.6.0
DrugCentral Indication
DrugCentral
etanercept